Belumosudil 200mg tablets
NHS hospitals in England used £27,275,444 of indicative cost of Belumosudil 200mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 34.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Belumosudil 200mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Belumosudil 200mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Royal Marsden Nhs Foundation Trust | £2,893,384 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,609,412 |
| The Clatterbridge Cancer Centre Nhs Ft | £2,535,624 |
| Manchester University Nhs Ft | £2,378,433 |
| Barts Health Nhs Trust | £2,096,026 |
| Imperial College Healthcare Nhs Trust | £1,829,495 |
| Nottingham University Hospitals Trust | £1,710,093 |
| Oxford University Hospitals Nhs Ft | £1,608,131 |
| University Hpls Of Leicester Nhs Trust | £1,455,636 |
| University Hospital Southampton Nhs Ft | £1,442,220 |
The primary-care picture
Belumosudil is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Belumosudil medicine page.